Bank Julius Baer & Co
BNGO icon

Bank Julius Baer & Co’s Bionano Genomics BNGO Stock Holding History

Bank Julius Baer & Co’s Portfolio BNGO Stock Details BNGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-1,027
Closed -$684K – 562
2023
Q1 		$684K Buy
1,027
+101
+11% +$89.7K ﹤0.01% 314
2022
Q4 		$811K Buy
926
+74
+9% +$93.1K 0.01% 292
2022
Q3 		$936K Sell
852
-1,078
-56% -$1.42M 0.01% 264
2022
Q2 		$1.6M Sell
1,930
-398
-17% -$410K 0.01% 229
2022
Q1 		$3.6M Sell
2,328
-612
-21% -$826K 0.02% 185
2021
Q4 		$5.28M Sell
2,940
-3,712
-56% -$9.93M 0.03% 196
2021
Q3 		$22M Buy
6,652
+2,139
+47% +$7.48M 0.14% 110
2021
Q2 		$19.8M Buy
4,513
+1,330
+42% +$5.25M 0.13% 123
2021
Q1 		$15.4M Buy
3,183
+1,766
+125% +$9.96M 0.12% 131
2020
Q4 		$2.62M Hold
1,417
– – 0.02% 242
2020
Q3 		$552K Buy
1,417
+167
+13% +$64.7K 0.01% 377
2020
Q2 		$382K Buy
1,250
+495
+66% +$124K ﹤0.01% 392
2020
Q1 		$205K Buy
+755
New +$426K ﹤0.01% 397

Other funds holding BNGO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $149B AUM 24.71% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank Julius Baer & Co's BNGO Position: Q2 2023 in Review

Bank Julius Baer & Co sold out of Bionano Genomics (BNGO) in Q2 2023, closing a stake of 1,027 shares — an estimated $684K sold.

Bank Julius Baer & Co first reported a position in BNGO in Q1 2020 and held it in 13 quarters. The position peaked at $22M in Q3 2021. 108 funds tracked by Wall St. Rank hold BNGO as of Q2 2023.

  • Bank Julius Baer & Co reported no remaining Bionano Genomics position as of Q2 2023 after selling out during the quarter.
  • Bank Julius Baer & Co sold 1,027 Bionano Genomics shares in Q2 2023, an estimated $684K.
  • Bank Julius Baer & Co first reported a position in Bionano Genomics in Q1 2020 and held it in 13 quarters.
  • Bank Julius Baer & Co's Bionano Genomics position peaked at $22M in Q3 2021.
  • 108 funds tracked by Wall St. Rank held Bionano Genomics as of Q2 2023.

Based on Bank Julius Baer & Co's 13F filing for Q2 2023, filed 20 Jul 2023.